DENTSPLY SIRONA Future Growth

Future criteria checks 4/6

DENTSPLY SIRONA is forecast to grow earnings and revenue by 73.9% and 1.2% per annum respectively. EPS is expected to grow by 77.1% per annum. Return on equity is forecast to be 16.6% in 3 years.

Key information

73.9%

Earnings growth rate

77.1%

EPS growth rate

Medical Equipment earnings growth18.9%
Revenue growth rate1.2%
Future return on equity16.6%
Analyst coverage

Good

Last updated11 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

WBAG:XRAY - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,907219368N/A12
12/31/20253,78617032349714
12/31/20243,813-43731052413
9/30/20243,900-413365534N/A
6/30/20243,896-185364527N/A
3/31/20243,940-95279423N/A
12/31/20233,965-132228377N/A
9/30/20233,936-214218359N/A
6/30/20233,936-1,025198334N/A
3/31/20233,931-1,038259403N/A
12/31/20223,922-950368517N/A
9/30/20224,042-816439597N/A
6/30/20224,135345499660N/A
3/31/20224,174368545701N/A
12/31/20214,231411515657N/A
9/30/20214,207401584712N/A
6/30/20214,062370634748N/A
3/31/20213,491179617708N/A
12/31/20203,339-73562649N/A
9/30/20203,371-80575672N/A
6/30/20203,438-48524623N/A
3/31/20203,95784479594N/A
12/31/20194,022256516639N/A
9/30/20193,977162397536N/A
6/30/20193,944105337502N/A
3/31/20193,976-1,053291474N/A
12/31/20183,986-1,011312500N/A
9/30/20184,018-1,663345527N/A
6/30/20184,098-1,601N/A565N/A
3/31/20184,049-1,529N/A575N/A
12/31/20173,993-1,550N/A602N/A
9/30/20173,899-793N/A595N/A
6/30/20173,844-791N/A584N/A
3/31/20173,873365N/A645N/A
12/31/20163,745430N/A563N/A
9/30/20163,420382N/A467N/A
6/30/20163,115374N/A474N/A
3/31/20162,791312N/A433N/A
12/31/20152,674251N/A497N/A
9/30/20152,722277N/A564N/A
6/30/20152,782268N/A551N/A
3/31/20152,849314N/A561N/A
12/31/20142,923323N/A560N/A
9/30/20142,957313N/A527N/A
6/30/20142,953317N/A506N/A
3/31/20142,949314N/A446N/A
12/31/20132,951313N/A418N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: XRAY is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.4%).

Earnings vs Market: XRAY is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: XRAY is expected to become profitable in the next 3 years.

Revenue vs Market: XRAY's revenue (1.2% per year) is forecast to grow faster than the Austrian market (0.7% per year).

High Growth Revenue: XRAY's revenue (1.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: XRAY's Return on Equity is forecast to be low in 3 years time (16.6%).


Discover growth companies